# Fremanezumab for the Preventive Treatment of Chronic Migraine

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/fremanezumab-for-the-preventive-treatment-of-chronic-migraine/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Stephen D. Silberstein,David W. Dodick,Marcelo E. Bigal,Paul Yeung,Peter J. Goadsby,Tricia Blankenbiller,Melissa Grozinski‐Wolff,Ronghua Yang,Yuju Ma,Ernesto Aycardi |
| Citations | 811 |
| DOI | 10.1056/nejmoa1709038 |
| Fields | Medicine |
| Open Access | true |
| OA Status | green |
| OA URL | https://jdc.jefferson.edu/neurologyfp/145 |
| OpenAlex ID | https://openalex.org/W2768357559 |
| PMID | 29171818 |
| Type | article |
| Year | 2017 |

## Paper authors

- [David W. Dodick](https://scholariq.org/researchers/david-w-dodick/)

## Paper journal

- [New England Journal of Medicine](https://scholariq.org/journals/new-england-journal-of-medicine/)

## Paper primary topic

- [Migraine and Headache Studies](https://scholariq.org/topics/migraine-and-headache-studies/)

## Paper topics

- [Migraine and Headache Studies](https://scholariq.org/topics/migraine-and-headache-studies/)
- [Cerebrovascular and genetic disorders](https://scholariq.org/topics/cerebrovascular-and-genetic-disorders/)
- [Neurological Complications and Syndromes](https://scholariq.org/topics/neurological-complications-and-syndromes/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.